Product information and disease description
Place of product in therapy
153 evidence topics · 47 sources
Atebrioz (zilurgisertib)
Fibrodysplasia ossificans progressiva
- Manufacturer
- Mirum Pharmaceuticals
- Regulatory submission
- NDA submitted by May 2026
- Last updated